References
- MelladoBJimenezNMarin-AguileraMReigODiving into cabazitaxel mode of action; more than a taxane for the treatment of castration resistance prostate cancer patientsClin Genitourin Cancer Epub20151228
- ZhuangBDuLXuHSelf-assembled micelle loading cabazitaxel for therapy of lung cancerInt J Pharm20164991–214615526762884
- MoriceauGGuillotAPacautCTranslating clinical evidence-based medicine into the real world: single-center experience with cabazitaxel in metastatic prostate cancer patientsChemotherapy201661312713326757168
- HeZSchulzAWanXPoly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluationJ Control Release2015208677525725361
- CoorsEASeyboldHMerkHFMahlerVPolysorbate 80 in medical products and nonimmunologic anaphylactoid reactionsAnn Allergy Asthma Immunol200595659359916400901
- GaoYXieJChenHNanotechnology-based intelligent drug design for cancer metastasis treatmentBiotechnol Adv201432476177724211475
- KraftJCFreelingJPWangZHoRJEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsJ Pharm Sci20141031295224338748
- GoyalRMacriLKKaplanHMKohnJNanoparticles and nanofibers for topical drug deliveryJ Control Release Epub20151028
- ReddyLHBazileDDrug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeuticsAdv Drug Deliv Rev201471345724184489
- CuiWWangAZhaoJYangXCaiPLiJLayer by layer assembly of albumin nanoparticles with selective recognition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)J Colloid Interface Sci2016465111726641559
- WanXZhengXPangXZhangZZhangQIncorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancerColloids Surf B Biointerfaces201513681782726539808
- QuGWuXYinLZhangCN-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokineticsBiomed Pharmacother2012661465122264883
- WeiszharZCzuczJReveszCRosivallLSzebeniJRozsnyayZComplement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20Eur J Pharm Sci201245449249821963457
- QuNSunYTXieJTengLSPreparation and evaluation of self-assembling HSA nanoparticles for cabazitaxel in vitroAnti-Cancer Agents Med Chem Epub2016525
- ZhangJHanJZhangXLPolymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxelCarbohydr Polym2015129253426050884
- CaoJChenYWWangXLuoXLEnhancing blood compatibility of biodegradable polymers by introducing sulfobetaineJ Biomed Mater Res A201197447247921495169
- SingerEASrinivasanRIntravenous therapies for castration-resistant prostate cancer: toxicities and adverse eventsUrol Oncol2012304 SupplS15S1922014836
- KaraveliogluEGonulYAksitHCabazitaxel causes a dose-dependent central nervous system toxicity in ratsJ Neurol Sci2016360667126723976
- LiCLiYGaoYDirect comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?Int J Pharm20144681–2152524709221
- PourjavadiATehraniZMMesoporous silica nanoparticles with bilayer coating of poly(acrylic acid-co-itaconic acid) and human serum albumin (HSA): A pH-sensitive carrier for gemcitabine deliveryMater Sci Eng C Mater Biol Appl20166178279026838909
- OgnibeneAGrandiGLorubbioMKDIGO 2012 clinical practice guideline CKD classification rules out creatinine clearance 24 hour urine collection?Clin Biochem2016491858926232286
- ShashidharKNMunilakshmiUPrabhavathiKReddyMLakshmaiahVPotential role of uric acid in correlation with epidemics of hypertension and albumin creatinine ratio in diabetic nephropathyApollo Med20151312430
- ShavitLLifschitzMGalperinIInfluence of enteric nutrition on blood urea nitrogen (BUN) in very old patients with chronic kidney disease (CKD)Arch Gerontol Geriatr201254122823121492948